Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ImmuneSensor Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
ImmuneSensor Therapeutics

ImmuneSensor Therapeutics

Series A

ImmuneSensor Therapeutics: A biotech firm innovating novel medicinal solutions.

HQ
Dallas, TX, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

ImmuneSensor Therapeutics, founded with a mission to harness the innate immune system, focuses on developing novel medicines to treat inflammation, autoimmune diseases, and cancer. The company leverages the cGAS-STING pathway to create innovative therapeutic applications. Their product pipeline includes IMSA101 and a drug conjugate platform featuring cGAS inhibitors, targeting critical areas in immunotherapy and disease treatment.

Notable figures affiliated with ImmuneSensor Therapeutics include leading experts in immunology and biotechnology. The company has attracted significant investment from prominent venture capital firms in the biotech sector. Key achievements include advancing their clinical trials and presenting groundbreaking research in major scientific publications. ImmuneSensor Therapeutics has made a substantial impact by pushing the boundaries of immunotherapy and offering new hope for patients with challenging conditions.

ImmuneSensor Therapeutics - Similar Companies

Inimmune logo

Inimmune

inimmune.com

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Immuneering logo

Immuneering

immuneering.com

Inmagene Biopharmaceuticals logo

Inmagene Biopharmaceuticals

inmagenebio.com

ImmuneID logo

ImmuneID

ImmuneBridge logo

ImmuneBridge

immunebridge.com

ImmunGene logo

ImmunGene

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

IM Therapeutics logo

IM Therapeutics

imtherapeutics.com

Immvention Therapeutix logo

Immvention Therapeutix

INmune Bio logo

INmune Bio

inmunebio.com

Asylia Therapeutics logo

Asylia Therapeutics

asyliatx.com

HI-Bio logo

HI-Bio

hibio.com

MindImmune Therapeutics logo

MindImmune Therapeutics

mindimmune.com

ImmuneSensor Therapeutics - Quick Facts

Who are ImmuneSensor Therapeutics' competitors?

Companies similar to ImmuneSensor Therapeutics include Inimmune, Immunitas Therapeutics, ImmunoGenesis and Immuneering.

When was ImmuneSensor Therapeutics founded?

ImmuneSensor Therapeutics was founded in 2019.

Where is ImmuneSensor Therapeutics' headquarters located?

ImmuneSensor Therapeutics' headquarters is located in Dallas, TX, US.

When was ImmuneSensor Therapeutics' last funding round?

ImmuneSensor Therapeutics' most recent funding round was for $10M (USD) in December 2022.

How much has ImmuneSensor Therapeutics raised to-date?

As of Dec 5, 2022, ImmuneSensor Therapeutics has raised a total of $26.1M (USD).

How many employees does ImmuneSensor Therapeutics have?

ImmuneSensor Therapeutics has 11 employees as of Feb 5, 2024.

ImmuneSensor Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified